Cargando…
DNA plasmid HIV vaccine design, number of doses, participant gender, and body mass index affect T-cell responses across HIV vaccine clinical trials
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441823/ http://dx.doi.org/10.1186/1742-4690-9-S2-P133 |
_version_ | 1782243384277073920 |
---|---|
author | Morgan, C Jin, X Yu, X De Rosa, S Kublin, J Metch, B Keefer, M NIAID, H |
author_facet | Morgan, C Jin, X Yu, X De Rosa, S Kublin, J Metch, B Keefer, M NIAID, H |
author_sort | Morgan, C |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3441823 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-34418232012-09-18 DNA plasmid HIV vaccine design, number of doses, participant gender, and body mass index affect T-cell responses across HIV vaccine clinical trials Morgan, C Jin, X Yu, X De Rosa, S Kublin, J Metch, B Keefer, M NIAID, H Retrovirology Poster Presentation BioMed Central 2012-09-13 /pmc/articles/PMC3441823/ http://dx.doi.org/10.1186/1742-4690-9-S2-P133 Text en Copyright ©2012 Morgan et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Poster Presentation Morgan, C Jin, X Yu, X De Rosa, S Kublin, J Metch, B Keefer, M NIAID, H DNA plasmid HIV vaccine design, number of doses, participant gender, and body mass index affect T-cell responses across HIV vaccine clinical trials |
title | DNA plasmid HIV vaccine design, number of doses, participant gender, and body mass index affect T-cell responses across HIV vaccine clinical trials |
title_full | DNA plasmid HIV vaccine design, number of doses, participant gender, and body mass index affect T-cell responses across HIV vaccine clinical trials |
title_fullStr | DNA plasmid HIV vaccine design, number of doses, participant gender, and body mass index affect T-cell responses across HIV vaccine clinical trials |
title_full_unstemmed | DNA plasmid HIV vaccine design, number of doses, participant gender, and body mass index affect T-cell responses across HIV vaccine clinical trials |
title_short | DNA plasmid HIV vaccine design, number of doses, participant gender, and body mass index affect T-cell responses across HIV vaccine clinical trials |
title_sort | dna plasmid hiv vaccine design, number of doses, participant gender, and body mass index affect t-cell responses across hiv vaccine clinical trials |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441823/ http://dx.doi.org/10.1186/1742-4690-9-S2-P133 |
work_keys_str_mv | AT morganc dnaplasmidhivvaccinedesignnumberofdosesparticipantgenderandbodymassindexaffecttcellresponsesacrosshivvaccineclinicaltrials AT jinx dnaplasmidhivvaccinedesignnumberofdosesparticipantgenderandbodymassindexaffecttcellresponsesacrosshivvaccineclinicaltrials AT yux dnaplasmidhivvaccinedesignnumberofdosesparticipantgenderandbodymassindexaffecttcellresponsesacrosshivvaccineclinicaltrials AT derosas dnaplasmidhivvaccinedesignnumberofdosesparticipantgenderandbodymassindexaffecttcellresponsesacrosshivvaccineclinicaltrials AT kublinj dnaplasmidhivvaccinedesignnumberofdosesparticipantgenderandbodymassindexaffecttcellresponsesacrosshivvaccineclinicaltrials AT metchb dnaplasmidhivvaccinedesignnumberofdosesparticipantgenderandbodymassindexaffecttcellresponsesacrosshivvaccineclinicaltrials AT keeferm dnaplasmidhivvaccinedesignnumberofdosesparticipantgenderandbodymassindexaffecttcellresponsesacrosshivvaccineclinicaltrials AT niaidh dnaplasmidhivvaccinedesignnumberofdosesparticipantgenderandbodymassindexaffecttcellresponsesacrosshivvaccineclinicaltrials |